Aldosterone as a cardiovascular risk factor
Authors:
- Marco BoscaroMBMarco Boscaro
- Vanessa RonconiVRVanessa Ronconi
- John W. FunderJFJohn W. Funder
- 1 April 2005
- journal article
- review article
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 16 (3) , 104-107
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Effect of 3β-hydroxysteroid dehydrogenase inhibition by trilostane on blood pressure in the Dahl salt-sensitive ratAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2005
- Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatmentHeart, 2004
- Myocardial Ultrasonic Backscatter in HypertensionHypertension, 2003
- Excess ldosterone Is Associated With Alterations of Myocardial Texture in Primary AldosteronismHypertension, 2002
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropinThe Journal of Clinical Endocrinology & Metabolism, 1996
- Changes in Left Ventricular Anatomy and Function in Hypertension and Primary AldosteronismHypertension, 1996
- Vasodilation to acetylcholine in primary and secondary forms of human hypertension.Hypertension, 1993
- Left ventricular structural characteristics in unilateral renovascular hypertension and primary aldosteronismThe American Journal of Cardiology, 1988
- Glucocorticoid and mineralocorticoid receptors for aldosteroneJournal of Steroid Biochemistry, 1972